PL346861A1 - Bifunctional antibodies and their use in targeting anti-tumour agents - Google Patents

Bifunctional antibodies and their use in targeting anti-tumour agents

Info

Publication number: PL346861A1
Authority: PL; Poland
Prior art keywords: bifunctional antibodies; tumour agents; targeting anti; targeting; tumour
Prior art date: 1998-09-04

Application number

PL99346861A

Inventor

Peter John Harrison

Original Assignee

Ks Biomedix Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-04

Filing date

1999-09-06

Publication date

2002-03-11

1999-09-06 Application filed by Ks Biomedix Ltd filed Critical Ks Biomedix Ltd

2002-03-11 Publication of PL346861A1 publication Critical patent/PL346861A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cell Biology (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Epidemiology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

PL99346861A 1998-09-04 1999-09-06 Bifunctional antibodies and their use in targeting anti-tumour agents PL346861A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9819411.1A GB9819411D0 (en)	1998-09-04	1998-09-04	Antibodies
PCT/GB1999/002938 WO2000014119A2 (en)	1998-09-04	1999-09-06	Bifunctional antibodies and their use in targeting anti-tumour agents

Publications (1)

Publication Number	Publication Date
PL346861A1 true PL346861A1 (en)	2002-03-11

Family

ID=10838416

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL99346861A PL346861A1 (en)	1998-09-04	1999-09-06	Bifunctional antibodies and their use in targeting anti-tumour agents

Country Status (20)

Country	Link
EP (1)	EP1107995A2 (en)
JP (1)	JP2002524470A (en)
KR (1)	KR20010072988A (en)
CN (1)	CN1315967A (en)
AU (1)	AU5641299A (en)
BG (1)	BG105293A (en)
BR (1)	BR9913429A (en)
CA (1)	CA2341753A1 (en)
EA (1)	EA200100311A1 (en)
GB (1)	GB9819411D0 (en)
HR (1)	HRP20010154A2 (en)
HU (1)	HUP0104091A2 (en)
ID (1)	ID28873A (en)
IL (1)	IL141524A0 (en)
MX (1)	MXPA01002349A (en)
NO (1)	NO20011102L (en)
PL (1)	PL346861A1 (en)
TR (2)	TR200103405T2 (en)
WO (1)	WO2000014119A2 (en)
ZA (1)	ZA200101574B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US11987629B2 (en)	2018-06-01	2024-05-21	Tayu Huaxia Biotech Medical Group Co., Ltd.	Compositions and uses thereof for treating disease or condition
WO2019227490A1 (en)	2018-06-01	2019-12-05	Tayu Huaxia Biotech Medical Group Co., Ltd.	Compositions and methods for imaging
EP3826673A4 (en) *	2018-07-26	2022-03-09	Tayu Huaxia Biotech Medical Group Co., Ltd.	Compositions and methods for imaging
CN113795511B (en)	2019-01-23	2024-07-23	大有华夏生物医药集团有限公司	Anti-PD-L1 double antibody and its use
CN110811820B (en) *	2019-12-11	2022-07-12	江西华晨医疗设备有限公司	Straight rod type flushing and suction electrocoagulation cutter

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4474893A (en) *	1981-07-01	1984-10-02	The University of Texas System Cancer Center	Recombinant monoclonal antibodies
IL89491A0 (en) *	1988-11-17	1989-09-10	Hybritech Inc	Bifunctional chimeric antibodies
US5217713A (en) *	1988-12-27	1993-06-08	Takeda Chemical Industries, Ltd.	Cytotoxic bispecific monoclonal antibody, its production and use
CA2069439A1 (en) *	1989-12-15	1991-06-16	Susumu Iwasa	Monoclonal antibodies, their production and use
JPH05184383A (en) *	1990-06-19	1993-07-27	Dainabotsuto Kk	Bispecific antibody
WO1998038513A1 (en) *	1997-02-26	1998-09-03	Khaw Ban An	Signal enhancement of bispecific antibody-polymer probe for immunoassay use

1998
- 1998-09-04 GB GBGB9819411.1A patent/GB9819411D0/en not_active Ceased
1999
- 1999-09-06 CN CN99810368A patent/CN1315967A/en active Pending
- 1999-09-06 KR KR1020017002437A patent/KR20010072988A/en not_active Withdrawn
- 1999-09-06 MX MXPA01002349A patent/MXPA01002349A/en not_active Application Discontinuation
- 1999-09-06 WO PCT/GB1999/002938 patent/WO2000014119A2/en not_active Ceased
- 1999-09-06 HU HU0104091A patent/HUP0104091A2/en unknown
- 1999-09-06 ID IDW20010752A patent/ID28873A/en unknown
- 1999-09-06 BR BR9913429-2A patent/BR9913429A/en not_active IP Right Cessation
- 1999-09-06 JP JP2000568876A patent/JP2002524470A/en active Pending
- 1999-09-06 AU AU56412/99A patent/AU5641299A/en not_active Abandoned
- 1999-09-06 IL IL14152499A patent/IL141524A0/en unknown
- 1999-09-06 TR TR2001/03405T patent/TR200103405T2/en unknown
- 1999-09-06 TR TR2001/00651T patent/TR200100651T2/en unknown
- 1999-09-06 EP EP99943138A patent/EP1107995A2/en not_active Withdrawn
- 1999-09-06 CA CA002341753A patent/CA2341753A1/en not_active Abandoned
- 1999-09-06 HR HR20010154A patent/HRP20010154A2/en not_active Application Discontinuation
- 1999-09-06 EA EA200100311A patent/EA200100311A1/en unknown
- 1999-09-06 PL PL99346861A patent/PL346861A1/en not_active Application Discontinuation
2001
- 2001-02-26 BG BG105293A patent/BG105293A/en unknown
- 2001-02-26 ZA ZA200101574A patent/ZA200101574B/en unknown
- 2001-03-02 NO NO20011102A patent/NO20011102L/en unknown

Also Published As

Publication number	Publication date
BR9913429A (en)	2001-09-25
WO2000014119A3 (en)	2000-11-30
TR200103405T2 (en)	2002-06-21
AU5641299A (en)	2000-03-27
EP1107995A2 (en)	2001-06-20
HUP0104091A2 (en)	2002-03-28
JP2002524470A (en)	2002-08-06
KR20010072988A (en)	2001-07-31
EA200100311A1 (en)	2001-08-27
CA2341753A1 (en)	2000-03-16
HRP20010154A2 (en)	2002-02-28
GB9819411D0 (en)	1998-10-28
BG105293A (en)	2001-12-29
NO20011102D0 (en)	2001-03-02
WO2000014119A2 (en)	2000-03-16
CN1315967A (en)	2001-10-03
ZA200101574B (en)	2002-02-26
NO20011102L (en)	2001-03-05
IL141524A0 (en)	2002-03-10
TR200100651T2 (en)	2001-07-23
ID28873A (en)	2001-07-12
MXPA01002349A (en)	2003-10-15

Publication	Publication Date	Title
DE69834346D1 (en)	2006-06-01	Proteinexpression in baculovirus-vektor expressionsystemen
IL139286A0 (en)	2001-11-25	Polyol-ifn-beta conjugates, their preparation and use
IL183948A (en)	2010-11-30	Peg-urate oxidase conjugates and use thereof
GB2320435B (en)	1998-10-28	Improvements in Magnotherapy
HUP0000651A3 (en)	2001-12-28	Conjugates useful in the treatment of prostate cancer
GB9717588D0 (en)	1997-10-22	Improvements in or relating to contrast agents
IL136167A0 (en)	2001-05-20	Conjugates useful in the treatment of prostate cancer
GB9425600D0 (en)	1995-02-15	Targeting complexes and use thereof
IL135803A0 (en)	2001-05-20	Lipid mixtures and their use
GB9725946D0 (en)	1998-02-04	Lipid compositions and their use
PL346861A1 (en)	2002-03-11	Bifunctional antibodies and their use in targeting anti-tumour agents
ZA9810974B (en)	1999-06-03	Conjugates useful in the treatment of prostate cancer
GB9717589D0 (en)	1997-10-22	Improvements in or relating to contrast agents
GB9701237D0 (en)	1997-03-12	Improvements in or relating to contrast agents
GB2316359B (en)	2000-09-13	Combined greeting and cheque
GB9805630D0 (en)	1998-05-13	Improvements in creamic materials
GB9702652D0 (en)	1997-04-02	Conjugates and their preparation
GB2321428B (en)	1999-04-07	Improvements in marketing
GB9816014D0 (en)	1998-09-23	Piperidinecarboxamides and their use
GB9718160D0 (en)	1997-10-29	Conjugates useful in the treatment of prostate cancer
GB9715323D0 (en)	1997-09-24	Piperidinecarboxamides and their use
GB9813825D0 (en)	1998-08-26	Improvements in anti-hiv-1 and anticancer agents
GB9706758D0 (en)	1997-05-21	Compositions and their use
GB9626309D0 (en)	1997-02-05	Conjugates useful in the treatment of prostate cancer
GB9624170D0 (en)	1997-01-08	Conjugates useful in the treatment of prostate cancer

Legal Events

Date	Code	Title	Description
2008-05-30	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)